Polymorphisms of EpCAM gene and prognosis for non-small-cell lung cancer in Han Chinese

Authors

  • Yuefan Yang,

    1. Department of Neurosurgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, China
    Search for more papers by this author
    • These authors contributed equally to this work.
  • Fei Fei,

    1. State Key Laboratory of Cancer Biology, Cell Engineering Research Center and Department of Cell Biology, The Fourth Military Medical University, Xi'an, China
    Search for more papers by this author
    • These authors contributed equally to this work.
  • Yang Song,

    1. Department of Oncology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China
    Search for more papers by this author
  • Xiaofei Li,

    1. Department of Thoracic Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China
    Search for more papers by this author
  • Zhipei Zhang,

    1. Department of Thoracic Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China
    Search for more papers by this author
  • Zhou Fei,

    1. Department of Neurosurgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, China
    Search for more papers by this author
  • Haichuan Su,

    Corresponding author
    1. Department of Oncology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China
    • Shaogui Wan, Pharmaceutical College of Henan University, Jinming District, Kaifeng, Henan 475001, China.

      Tel: +86-29-84773159; Fax: +86-29-84772286;

      E-mail: shaoguiwan@hotmail.com

      Haichuan Su, Department of Oncology, Tangdu Hospital, The Fourth Military Medical University, 569 Xinsi Road, Xi'an 710038, China.

      Tel: +86-29-84778455; Fax: +86-29-84778455;

      E-mail: suhc@fmmu.edu.cn

    Search for more papers by this author
  • Shaogui Wan

    Corresponding author
    1. Pharmaceutical College of Henan University, Kaifeng, Henan, China
    • Shaogui Wan, Pharmaceutical College of Henan University, Jinming District, Kaifeng, Henan 475001, China.

      Tel: +86-29-84773159; Fax: +86-29-84772286;

      E-mail: shaoguiwan@hotmail.com

      Haichuan Su, Department of Oncology, Tangdu Hospital, The Fourth Military Medical University, 569 Xinsi Road, Xi'an 710038, China.

      Tel: +86-29-84778455; Fax: +86-29-84778455;

      E-mail: suhc@fmmu.edu.cn

    Search for more papers by this author

  • Funding Information

    Program for New Century Excellent Talents in University (No. 81201583), and National Key Scientific and Technological Project (No. 2011ZX09307-001-04).

Abstract

The epithelial cell adhesion molecule (EpCAM) is overexpressed in a wide variety of human cancers and is associated with patient prognosis, including those with lung cancer. However, the association of single nucleotide polymorphisms (SNPs) in the EpCAM gene with the prognosis for non-small-cell lung cancer (NSCLC) patients has never been investigated. We evaluated the association between two SNPs, rs1126497 and rs1421, in the EpCAM gene and clinical outcomes in a Chinese cohort of 506 NSCLC patients. The SNPs were genotyped using the Sequenom iPLEX genotyping system. Multivariate Cox proportional hazards model and Kaplan–Meier curves were used to assess the association of EpCAM gene genotypes with the prognosis of NSCLC. We found that the non-synonymous SNP rs1126497 was significantly associated with survival. Compared with the CC genotype, the CT+TT genotype was a risk factor for both death (hazard ratio, 1.40; 95% confidence interval [CI], 1.02–1.94; = 0.040) and recurrence (hazard ratio, 1.34; 95% CI, 1.02–1.77; = 0.039). However, the SNP rs1421 did not show any significant effect on patient prognosis. Instead, the AG+GG genotype in rs1421 was significantly associated with early T stages (T1/T2) when compared with the AA genotype (odds ratio for late stage = 0.65; 95% CI, 0.44–0.96, P = 0.029). Further stratified analysis showed notable modulating effects of clinical characteristics on the associations between variant genotypes of rs1126497 and NSCLC outcomes. In conclusion, our study indicated that the non-synonymous SNP rs1126497 may be a potential prognostic marker for NSCLC patients.

Ancillary